These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 4627387)

  • 1. [Method of labelled inhibitors and its applications].
    Przegl Lek; 1972; 29(7):663-9. PubMed ID: 4627387
    [No Abstract]   [Full Text] [Related]  

  • 2. The metabolic fate of tritiated methotrexate. I. Absorption, excretion, and distribution in mice, rats, dogs and monkeys.
    Henderson ES; Adamson RH; Denham C; Oliverio VT
    Cancer Res; 1965 Aug; 25(7):1008-17. PubMed ID: 4954195
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on folic reductase. 3. The level of enzyme activity and response to methotrexate of transplantable mouse tumors.
    Roberts D; Wodinsky I; Hall TC
    Cancer Res; 1965 Dec; 25(11):1899-903. PubMed ID: 5856519
    [No Abstract]   [Full Text] [Related]  

  • 4. [Site of action of the coronary medication, carbochromen].
    Alfes H; Schraven E; Möllmann H; Ostrowski J; Bigalke G; Nitz RE
    Brux Med; 1974 May; 54(5):303-8. PubMed ID: 4214587
    [No Abstract]   [Full Text] [Related]  

  • 5. Methotrexate binding to dihydrofolate reductase.
    Roberts GC; Feeney J; Birdsall B; Charlton P; Young D
    Nature; 1980 Jul; 286(5770):309. PubMed ID: 7402318
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of inhibitors in studies of comparative enzymology.
    Hitchings GH
    Fed Proc; 1967; 26(4):1078-81. PubMed ID: 6028773
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent concepts on the mechanism of action of methotrexate.
    White JC
    Cancer Treat Rep; 1981; 65 Suppl 1():3-12. PubMed ID: 7326663
    [No Abstract]   [Full Text] [Related]  

  • 8. Conformational analysis of methotrexate.
    Takle H; Olagappan N; Gupta SP
    Res Commun Chem Pathol Pharmacol; 1985 Nov; 50(2):233-43. PubMed ID: 3909272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organic radiopharmaceuticals labeled with isotopes of short half-life. V. 18 F-labeled 5- and 6-fluorotryptophan.
    Atkins HL; Christman DR; Fowler JS; Hauser W; Hoyte RM; Klopper JF; Lin SS; Wolf AP
    J Nucl Med; 1972 Oct; 13(10):713-9. PubMed ID: 5056684
    [No Abstract]   [Full Text] [Related]  

  • 10. Models for the binding of methotrexate to Escherichia coli dihydrofolate reductase: direct effect of carboxylate of aspartic acid 27 upon ultraviolet spectrum of methotrexate.
    Schlegel HB; Poe M; Hoogsteen K
    Mol Pharmacol; 1981 Jul; 20(1):154-8. PubMed ID: 7027022
    [No Abstract]   [Full Text] [Related]  

  • 11. Ultrastructural localization and distribution of free cholesterol (3-beta-hydroxysterols) in tissues.
    Williamson JR
    J Ultrastruct Res; 1969 Apr; 27(2):118-33. PubMed ID: 4890150
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxicity of methotrexate and metoprine in a dihydrofolate reductase gene-amplified mouse cell line.
    Hamrell M; Laszlo J; Brown OE; Sedwick WD
    Mol Pharmacol; 1981 Nov; 20(3):637-43. PubMed ID: 7329406
    [No Abstract]   [Full Text] [Related]  

  • 13. [Synthesis of radioactively labelled tetroxoprim (author's transl)].
    Buchtela K; Liebenow W; Vergin H
    Arzneimittelforschung; 1980; 30(2):307-9. PubMed ID: 7378109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electron microscopic observations of L-lactate dehydrogenase crystals.
    Labaw LW; Rossmann MG
    J Ultrastruct Res; 1969 Apr; 27(1):105-17. PubMed ID: 5779916
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current topics in radiopharmaceuticals in Japan. (IV). Quality control of "Kit" made radiopharmaceuticals--radiochemical purity of 99mTc radiopharmaceuticals].
    Yokoyama A
    Radioisotopes; 1984 Mar; 33(3):170-9. PubMed ID: 6382453
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of the rates of synthesis and degradation of enzymes by complex formation with radioactive ligands.
    Hanggi UJ
    FEBS Lett; 1976 Sep; 68(1):35-7. PubMed ID: 964378
    [No Abstract]   [Full Text] [Related]  

  • 17. Methotrexate. I. Pharmacology and pharmacokinetics.
    Lippens RJ
    Am J Pediatr Hematol Oncol; 1984; 6(4):379-95. PubMed ID: 6398629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the cellular oxidation-reduction state in methotrexate binding to dihydrofolate reductase and dissociation induced by reduced folates.
    Matherly LH; Anderson LA; Goldman ID
    Cancer Res; 1984 Jun; 44(6):2325-30. PubMed ID: 6609765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The metabolism of drugs labelled with C14 and H3: from animal experimentation to use in man].
    Glasson B; Benakis A
    Rev Eur Etud Clin Biol; 1971 Mar; 16(3):209-15. PubMed ID: 5555987
    [No Abstract]   [Full Text] [Related]  

  • 20. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells.
    Chu BC; Fan CC; Howell SB
    J Natl Cancer Inst; 1981 Jan; 66(1):121-4. PubMed ID: 6935452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.